Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-145347
Filing Date
2025-06-24
Accepted
2025-06-24 08:31:04
Documents
7
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 6-K d80938d6k.htm 6-K 9390
2 EX-99.1 d80938dex991.htm EX-99.1 38734
3 EX-99.2 d80938dex992.htm EX-99.2 38917
4 EX-99.3 d80938dex993.htm EX-99.3 23713
5 GRAPHIC g80938g04g01.jpg GRAPHIC 18054
6 GRAPHIC g80938g04g02.jpg GRAPHIC 10931
7 GRAPHIC g80938g0624071612187.jpg GRAPHIC 2601
  Complete submission text file 0001193125-25-145347.txt   155703
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251066747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)